Home LiteratureArticle Details
PMID: 15470501 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Inefficient degradation of truncated polyglutamine proteins by the proteasome.

The EMBO journal ·Vol. 23 ·No. 21 ·2004-10-27 ·Pages 4307-18

Holmberg CI, Staniszewski KE, Mensah KN, Matouschek A, Morimoto RI

Abstract

Accumulation of mutant proteins into misfolded species and aggregates is characteristic for diverse neurodegenerative diseases including the polyglutamine diseases. While several studies have suggested that polyglutamine protein aggregates impair the ubiquitin-proteasome system, the molecular mechanisms underlying the interaction between polyglutamine proteins and the proteasome have remained elusive. In this study, we use fluorescence live-cell imaging to demonstrate that the proteasome is sequestered irreversibly within aggregates of overexpressed N-terminal mutant Huntingtin fragment or simple polyglutamine expansion proteins. Moreover, by direct targeting of polyglutamine proteins for proteasomal degradation, we observe incomplete degradation of these substrates both in vitro and in vivo. Thus, our data reveal that intrinsic properties of the polyglutamine proteins prevent their efficient degradation and clearance. Additionally, fluorescence resonance energy transfer is detected between the proteasome and aggregated polyglutamine proteins indicative of a close and stable interaction. We propose that polyglutamine-containing proteins are kinetically trapped within proteasomes, which could explain their deleterious effects on cellular function over time.

MeSH Terms
Cell Line Cysteine Endopeptidases/genetics,metabolism Fluorescence Recovery After Photobleaching Fluorescence Resonance Energy Transfer Humans Huntingtin Protein Luminescent Proteins/genetics,metabolism Nerve Tissue Proteins/chemistry,genetics,metabolism Neurodegenerative Diseases/metabolism Nuclear Proteins/chemistry,genetics,metabolism Peptides/chemistry,metabolism Proteasome Endopeptidase Complex/metabolism Protein Folding Recombinant Fusion Proteins/genetics,metabolism Ubiquitin/genetics,metabolism
Chemicals
HTT protein, human Huntingtin Protein Luminescent Proteins Nerve Tissue Proteins Nuclear Proteins Peptides Recombinant Fusion Proteins Ubiquitin LMP-2 protein polyglutamine Cysteine Endopeptidases Proteasome Endopeptidase Complex
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Holmberg Carina I
Department of Biochemistry, Molecular Biology and Cell Biology, Rice Institute for Biomedical Research, Robert H Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL 60208, USA.
Staniszewski Kristine E
Mensah Kwame N
Matouschek Andreas
Morimoto Richard I
References (36)
36 references, click to expand
  1. Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins.
    Mol Cell. 2004 Apr 9;14(1):95-104 PMID: 15068806
  2. Universality and structure of the N-end rule.
    J Biol Chem. 1989 Oct 5;264(28):16700-12 PMID: 2506181
  3. The N-end rule.
    Cell. 1992 May 29;69(5):725-35 PMID: 1317266
  4. The N-end rule: functions, mysteries, uses.
    Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12142-9 PMID: 8901547
  5. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
    Cell. 1997 Aug 8;90(3):537-48 PMID: 9267033
  6. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.
    Cell. 1997 Aug 8;90(3):549-58 PMID: 9267034
  7. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
    Science. 1997 Sep 26;277(5334):1990-3 PMID: 9302293
  8. Dynamics of proteasome distribution in living cells.
    EMBO J. 1997 Oct 15;16(20):6087-94 PMID: 9321388
  9. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.
    Neuron. 1999 Dec;24(4):879-92 PMID: 10624951
  10. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.
    Cell. 2000 Mar 31;101(1):57-66 PMID: 10778856
  11. Glutamine repeats and neurodegeneration.
    Annu Rev Neurosci. 2000;23:217-47 PMID: 10845064
  12. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.
    Hum Mol Genet. 2000 Nov 22;9(19):2799-809 PMID: 11092756
  13. Nucleolar components involved in ribosome biogenesis cycle between the nucleolus and nucleoplasm in interphase cells.
    J Cell Biol. 2001 Apr 2;153(1):169-76 PMID: 11285283
  14. Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression.
    J Cell Biol. 2001 Apr 16;153(2):283-94 PMID: 11309410
  15. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release.
    Hum Mol Genet. 2001 May 1;10(10):1049-59 PMID: 11331615
  16. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.
    Mol Biol Cell. 2001 May;12(5):1393-407 PMID: 11359930
  17. Impairment of the ubiquitin-proteasome system by protein aggregation.
    Science. 2001 May 25;292(5521):1552-5 PMID: 11375494
  18. Studying protein dynamics in living cells.
    Nat Rev Mol Cell Biol. 2001 Jun;2(6):444-56 PMID: 11389468
  19. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein.
    Hum Mol Genet. 2001 Jul 1;10(14):1441-8 PMID: 11448935
  20. ATP-dependent proteases degrade their substrates by processively unraveling them from the degradation signal.
    Mol Cell. 2001 Mar;7(3):627-37 PMID: 11463387
  21. Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease.
    J Neurosci. 2001 Nov 15;21(22):8772-81 PMID: 11698589
  22. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis.
    Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9310-5 PMID: 12084819
  23. Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions.
    Mol Cell. 2002 Aug;10(2):259-69 PMID: 12191472
  24. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components.
    Nat Cell Biol. 2002 Oct;4(10):806-10 PMID: 12360291
  25. Polyglutamine protein aggregates are dynamic.
    Nat Cell Biol. 2002 Oct;4(10):826-31 PMID: 12360295
  26. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy.
    Neuron. 2002 Aug 29;35(5):843-54 PMID: 12372280
  27. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders.
    Nature. 2003 Jan 23;421(6921):373-9 PMID: 12540902
  28. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice.
    Neuron. 2003 May 8;38(3):375-87 PMID: 12741986
  29. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.
    Cell. 2003 May 16;113(4):457-68 PMID: 12757707
  30. FRET or no FRET: a quantitative comparison.
    Biophys J. 2003 Jun;84(6):3992-4010 PMID: 12770904
  31. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration.
    Neuron. 2004 Mar 4;41(5):687-99 PMID: 15003169
  32. Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy.
    Biophys J. 1998 May;74(5):2702-13 PMID: 9591694
  33. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.
    Nat Genet. 1998 Jun;19(2):148-54 PMID: 9620770
  34. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.
    J Cell Biol. 1998 Dec 14;143(6):1457-70 PMID: 9852144
  35. FRET microscopy demonstrates molecular association of non-specific lipid transfer protein (nsL-TP) with fatty acid oxidation enzymes in peroxisomes.
    EMBO J. 1998 Dec 15;17(24):7179-89 PMID: 9857175
  36. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells.
    Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11404-9 PMID: 10500189
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
2004-10-27
Epub
2004-00-07
Pages
4307-18
Language
English
Region
England
NLM ID
8208664
PMCID
PMC524390
Subset
IM
Grants
NIGMS NIH HHS · GM63004 · United States
NIGMS NIH HHS · R37 GM038109 · United States
NIGMS NIH HHS · GM38109 · United States
NIGMS NIH HHS · T32 GM008061 · United States
NIGMS NIH HHS · R01 GM038109 · United States
NIGMS NIH HHS · T32GM08061 · United States
NIGMS NIH HHS · R01 GM063004 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]